George A. Digenis, Ph.D. - University of Kentucky - College of ...

"Chemically Active Filters for Modification of Smoke and Isolation of Bound Smoke
Components," Tobacco and Health Research Institute $63,499 (78-79).
"In Vivo Disposition of 18 F-haloperidol and 82 Br-bromperidol," National Institute of Health
$38,477 (78-79).
"Synthesis of Radiopharmaceutical's with Potential in the Diagnosis and Treatment of
Cancer," National Cancer Institute $26,390 (78-79).
"In Vitro and In Vivo Disposition of 13 N-Labeled Nitrosoamines plus Nitrosocarbamates,"
Tobacco and Health $41,650 (78-79).
"In Vivo Disposition of 18 F-haloperidol and 82 Br-bromperidol," National Institute of Health,
$31,270 (79-80).
"Physiologic Disposition of 13 N-Nitrosoureas and Their Potential as Tumor Localizing Agents,"
National Cancer Institute, $26,390 (79-80).
"Disposition of 13 N-Labeled Nitrosamines and Nitrosocarbamates," University of Kentucky
Tobacco and Health Research Institute, $41,650 (79-80).
"Preparation and Disposition of 11 C- D- and L-Amino Acids," National Institutes of Health,
$48,596 (80-81).
"Chemistry and in vivo Disposition of 13 N-labeled Nitrosoamines and Nitrosocarbamates,"
Tobacco and Health Research Institute, $45,022 (80-81).
"In Vivo Disposition of 18 F-haloperidol and 82 Br-bromperidol," National Institute of Health,
$29,082 (80-81).
"Biomedical Research Development Grant," National Institutes of Health $97,300 renewal
(81-82).
"Preparation and Disposition of 11 C- D- and L-Amino Acids,." National Institutes of Health,
$50,847 renewal (81-82).
"Development of Agents for Early Detection of and Susceptibility of Emphysema in Smokers,"
Tobacco and Health, $47,602 (81-82).
"Reducing Carcinogens in Cigarette Smoke by Selective Filters," National Cancer Institute,
$48,886 (81-82).
"Development of Agents for Early Detection of and Susceptibility to Emphysema in Smokers,"
Tobacco and Health, $58,390 (82-83).
"Preparation and Disposition of 11 C- D- and L-Amino Acids”: National Institutes of Health,
$51,137 (82-83).
"Development of Methodology for Following Microcapsule Transcervical Transport in Baboon
Utilizing External Scintigraphy," Program for Applied Research Fertility Regulation, $9,950
(82' ).
"External Scintigraphy to Study Disposition of Rectal Dosage Form Matrix In Vivo," INTER/x,
Merck, Sharp and Company, $16,000 (82').
Hoffman LaRoche Equipment Fund - upgrading the Baird Atomic System 70-crystal, $14,000
(82').
Upjohn Compnay - support for a magnet for the 13 C-NMR CFT-20 instrument $28,000 (82').
Tobacco and Health, "Development of Agents for Early Detection of a Susceptibility to
Emphysema in Smokers," $58,390 (3rd year renewal).
46